Clinical trial
More Options Available With a Quadripolar Left Ventricular (LV) Lead pRovidE In-clinic Solutions to Cardiac Resynchronization Therapy (CRT) Challenges
NCT01510652 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- More Options Available With a Quadripolar Left Ventricular (LV) Lead pRovidE In-clinic Solutions to Cardiac Resynchronization Therapy (CRT) Challenges
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- May 31, 2014
- Enrollment
- 1,078 (actual)
- Sites
- 64
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, inappropriate phrenic nerve stimulation, left ventricular cardiac dysfunction, perioperative/postoperative complications, postoperative cardiac complication